Related Experiment Videos

Interactions of natural effector cells and prostaglandins in the control of metastasis

Insights

Prostaglandin synthesis inhibition with indomethacin (INDO) reduced mammary tumor metastasis in mice. INDO enhanced tumor cell sensitivity to natural killer cells, suggesting a novel therapeutic approach for cancer metastasis.

Area of Science:

  • Immunology
  • Cancer Biology
  • Pharmacology

Background:

  • Prostaglandins and immune cells influence cancer growth and spread.
  • Murine mammary adenocarcinomas provide a model to study metastasis.

Purpose of the Study:

  • To investigate the roles of prostaglandins and immune cells in mammary tumor metastasis.
  • To evaluate the effects of indomethacin and poly I:C on tumor growth and metastasis.

Main Methods:

  • Administered indomethacin (INDO) and polyinosinic-polycytidylic acid (poly I:C) to mice with mammary tumors.
  • Assessed spontaneous and experimental metastasis.
  • Manipulated natural killer cell activity using anti-asialo GM1 (asGM1) antibody.
  • Cultured tumor cells with INDO before inoculation.

Main Results:

  • INDO inhibited spontaneous metastasis of 410.4 mammary tumors.
  • Poly I:C delayed tumor growth but did not affect spontaneous metastasis.
  • Poly I:C reduced experimental metastasis, while INDO had no significant effect on experimental metastasis when administered to recipients.
  • Suppression of natural killer cells increased lung colony formation.
  • Culturing tumor cells with INDO before inoculation inhibited experimental metastasis by over 90% in an asGM1-positive cell-dependent manner.

Conclusions:

  • Prostaglandin synthesis contributes to the metastatic capacity of murine mammary tumors.
  • Indomethacin's beneficial effects may stem from increased tumor cell sensitivity to natural cytotoxic mechanisms.
  • Targeting prostaglandin synthesis could be a strategy to combat cancer metastasis.

Related Concept Videos